Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

What Doctors Don't Tell You

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!
November 2019 (Vol. 4 Issue 9)

SSRI antidepressants don't work, independent study finds
About the author: 
Bryan Hubbard

SSRI antidepressants don't work, independent study finds image

The world's most commonly prescribed antidepressant doesn't work. Sertraline, marketed as Zoloft, has little or no effect on depression, concludes a study that is one of the first to be carried out without the funding of a drug company.

The results throw into question the effectiveness of SSRIs (selective serotonin reuptake inhibitors), a family of antidepressants that includes Prozac. Since their introduction in 1987, the SSRIs have become the standard treatment for depression.

But the way the drugs are supposed to combat depression has always been controversial—some manufacturers have even admitted they don't know how they work—and critics have said any effect is purely placebo.

In their review of sertraline—the most commonly prescribed antidepressant—researchers at University College London agree. They monitored the effects of sertraline on 326 patients with depression and compared them against 329 similar patients who were instead given a placebo. After six weeks, the improvements in the sertraline group was just 5 per cent as measured on a depression score, a result so weak that it could be discounted.

"We were shocked and surprised. We definitely need better treatments for depression, and we need more research in this area," said lead researcher Glyn Lewis. It was one of the first studies to be independent and not funded by a drug manufacturer; previous studies paid for by a drug company have invariably produced positive results.

Sertraline's one benefit was in treating anxiety, achieving a 24 percent reduction in symptoms after six weeks.


References

(Source: Lancet Psychiatry, 2019; published online, September 19, 2019; doi.org/10.1016/52235-9366(19)39366-9)

You may also be interested in...

Support WDDTY

Help support us to hold the drugs companies, governments and the medical establishment accountable for what they do.

Advertisements

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions..

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

© 2010 - 2019 WDDTY Publishing Ltd.
All Rights Reserved